GoGargle! sore throat remedy grows retail distribution
O’Connor Companies LLC has expanded retail distribution for GoGargle!, an effervescent salt gargle designed to provide a more refreshing option to relieve dry, irritated throats.
Supplier News
Procter & Gamble aims to spin off Duracell
As part of its strategy to sharpen its focus on core brands, Procter & Gamble Co. plans to spin off the Duracell battery business. P&G announced the plan Friday in reporting fiscal 2015 first-quarter earnings. The consumer products giant said that it’s exiting the battery business in two steps.
Lay’s announces ‘next great potato chip flavor’ winner
Lay’s Kettle Cooked Wasabi Ginger flavored potato chips emerged as the winner of this year’s Lay’s "Do Us A Flavor" contest by Frito-Lay.
Purdue kicks off pharmacist awareness campaign for Butrans
Purdue Pharma is working with the American Pharmacists Association (APhA) to distribute a series of resources that address pharmacist knowledge gaps with Butrans, the drug company’s Schedule III extended-release transdermal opioid pain medication.
General Mills wraps up Annie’s acquisition
General Mills Inc. has closed its acquisition of natural food company Annie’s Inc. General Mills said Tuesday that it completed its tender offer to buy Annie’s for $46 per share, or about $820 million. The deal was announced early last month.
L’Oreal USA to acquire Carol’s Daughter
L’Oreal USA has entered into an agreement to buy natural beauty products maker Carol’s Daughter. Financial terms of the transaction weren’t disclosed. The agreement is pending regulatory approval as well as other customary closing conditions.
H.D. Smith names new VP of sales
Rob Meriweather has been promoted to vice president of sales at H.D. Smith.
Topricin takes aim at children’s eczema
To help alleviate the discomfort and pain of children with eczema, Topical BioMedics Inc. has launched program in which it will send parents a free tube of its Topricin Junior for Children topical analgesic.
Takeda, Orexigen release Contrave obesity drug
Takeda Pharmaceuticals USA Inc. and Orexigen Therapeutics Inc. have shipped Contrave extended-release tablets, a weight management medication for obese adults, to U.S. pharmacies.
Horizon Pharma buys U.S. rights to Pennsaid 2%
Horizon Pharma plc has acquired the U.S. rights to arthritis treatment Pennsaid 2% from Nuvo Research Inc.
TriCalm earns National Eczema Association seal
Cosmederm Bioscience Inc.’s TriCalm Anti-Itch Hydrogel has been granted the National Eczema Association (NEA) Seal of Acceptance. The specialty pharmaceutical company said the seal recognizes TriCalm as a product appropriate for the care of itching related to eczema or sensitive skin.
AbbVie, Shire terminate merger deal
Drug makers AbbVie Inc. and Shire plc have canceled their proposed $54 billion merger agreement.
BioTerra supplements to hit shelves at Walgreens, Walmart
BioTerra Herbs is rolling out its non-GMO Project Verified supplements to Walgreens and Walmart brick-and-mortar and online stores. Digestion "belch" supplement from BioTerra Herbs.
AstraZeneca unveils Fit2Me diabetes support program
AstraZeneca has launched Fit2Me, a free diet and lifestyle support program that allows people with type 2 diabetes to create a personalized care plan.
GreatCall mobile health solutions for seniors launch at Rite Aid
GreatCall Inc. has rolled out its suite of connected health and safety products and services to more than 4,000 Rite Aid pharmacies nationwide.
Mirixa names Richardson as CEO
Marvin Richardson has been appointed chief executive officer of Mirixa Corp. The pharmacy-based patient care network said Tuesday that Richardson, who comes to the company from Walgreen Co., will take the CEO reins on Nov. 4 as well as become a member of the Mirixa board of directors.